Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00436306 · ClinicalTrials.gov registry record · Phase 4
Stage Matched Intervention to Increase Dual Method Use
A Phase 4 study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- Phase 4
- Development phase
- 550
- Enrollment target
NCT00436306 is a Phase 4 study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 550 participants.
The verdict
NCT00436306, a Phase 4 study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 550 participants
- Enrollment target
Study Summary
The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavior change. This intervention was compared to an enhanced standard care intervention that provided computer-based, non-tailored information and advice regarding the use of contraceptive methods. The two primary outcomes of this trial include: 1) a behavioral outcome: the reported use of dual methods of contraception; and 2) a biological outcome: an incident or recurrent STI or unintended pregnancy. The hypotheses of this trial were: 1) the individualized intervention will result in a greater increase in dual contraceptive use than the standard care approach; and 2) the individualized intervention would result in greater protection against incident or recurrent cases of sexually transmitted infections and unplanned pregnancies.
Interventions
- BEHAVIORAL Individualized Intervention
- BEHAVIORAL Computer-based contraceptive information
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 1999-10 |
| Est. Completion | 2005-12 |
| Phase | Phase 4 |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00436306
The ClinicalTrials.gov registry entry for NCT00436306 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Individualized Intervention is the first listed.
NCT00436306 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00436306 about?
NCT00436306 is a clinical study titled "Stage Matched Intervention to Increase Dual Method Use". The primary purpose of Project PROTECT was to evaluate two different intervention approaches that encourage young women to use dual methods of contraception. The individualized intervention is a computer assisted, fully-tailored, interactive intervention based on the transtheoretical model of behavi...
What is the current status of trial NCT00436306?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 550 participants. The study started on 1999-10. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00436306?
The interventions under investigation include: Individualized Intervention (BEHAVIORAL), Computer-based contraceptive information (BEHAVIORAL).
Who is sponsoring clinical trial NCT00436306?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.